DxO PureRAW 5 brings more control, a slicker workflow and beta DeepPRIME XD3 support for X-Trans Fujifilm owners ...

Atsuko Fukase formerly wrote about banking and M&A deals from The Wall Street Journal's Tokyo bureau.

FUJIFILM has invested about $4 billion in building biopharmaceutical manufacturing sites and life sciences capabilities.

Anthony Farina Fujifilm Holdings America Corporation has appointed Anthony Farina to the role of vice president, head of corporate communications, ...

Fujifilm can't make cameras fast enough to sell them in the U.S. Whether it's the cool kids' X100VI, the inexpensive ...

Pelthos Therapeutics, a Durham-based wholly owned subsidiary of Ligand Pharmaceuticals (Nasdaq: LGND), is combining with ...

W hen I was gifted the Fujifilm Instax Mini 12, I thought it was just another gadget I would never use, especially as someone ...

FujiFilm Diosynth plans to produce Regeneron's biologic medicines over 10 years in its Holly Springs facility, which is scheduled to begin operations this year.

On Tuesday, Fujifilm Diosynth announced a 10-year agreement worth more than $3 billion to make medicines for the New York drugmaker Regeneron in the Triangle. Regeneron is the facility’s third major ...

Anthony Farina, VP, head of corporate communications of Fujifilm Holdings America Corp. Photo courtesy of Fujifilms VALHALLA ...

SINGAPORE, April 23, 2025 /PRNewswire/ -- FUJIFILM Business Innovation Asia Pacific (FBAP) has been awarded the prestigious ...

Agreement secures additional U.S. manufacturing capacity to help ensure patient access to medicineHOLLY SPRINGS, N.C., April 23, 2025 -- ...